RA Capital Nexus Fund II, L.P. — SEC insider filings

SEC reporting owner CIK 1825376. 86 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers the 50 most recent of 86 filings on record, filed 2023-07-25 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PepGen Inc. (PEPG)Director63 legs · 20,557,593 sh · $100,337,790—3
Janux Therapeutics, Inc. (JANX)Director65 legs · 2,024,041 sh · $79,042,965—7
Hemab Therapeutics Holdings, Inc. (COAG)Director16 legs · 2,840,429 sh · $52,222,946—9
Climb Bio, Inc. (CLYM)Director95 legs · 13,330,218 sh · $50,732,442—18
ARS Pharmaceuticals, Inc. (SPRY)Director66 legs · 7,851,299 sh · $44,722,936—3
Acumen Pharmaceuticals, Inc. (ABOS)Director51 leg · 5,161,290 sh · $39,999,998—6
AN2 Therapeutics, Inc. (ANTX)10% owner21 leg · 1,777,778 sh · $16,000,0022 legs · 3,525,094 sh · $3,807,102—
LENZ Therapeutics, Inc. (LENZ)Director32 legs · 998,009 sh · $15,000,075—9
Boundless Bio, Inc. (BOLD)10% owner12 legs · 312,500 sh · $5,000,000—6
Werewolf Therapeutics, Inc. (HOWL)Director, 10% owner23 legs · 536,426 sh · $487,188—1

+4 more issuers among the filings shown — every filing appears in the table below.

Insider filings — RA Capital Nexus Fund II, L.P.

FiledFormIssuerReported transactionsSource
2026-11-174PepGen Inc. (PEPG)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 8,625,000 @ $5EDGAR
2026-09-304Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., Kolchinsky Peter, Shah Rajeev M.
Option exercise (M): 10,000 @ $3.46 · Option exercise (M): 10,000 @ $3 · Option exercise (M): 10,000 @ $7.89 · Option exercise (M): 40,000 @ $1.29 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · +2 moreEDGAR
2026-07-224Freenome, Inc. (FRNM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 6,561,711 · Grant/award (A): 970,950 · Grant/award (A): 553,703 · Grant/award (A): 908,103 · Grant/award (A): 367,427 · Grant/award (A): 4,918,411 @ $10 · +1 moreEDGAR
2026-07-014Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 70,284 (derivative) @ $0EDGAR
2026-06-264ARS Pharmaceuticals, Inc. (SPRY)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-224PepGen Inc. (PEPG)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 34,000 (derivative) @ $0EDGAR
2026-06-224Acrivon Therapeutics, Inc. (ACRV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 20,275 (derivative) @ $0EDGAR
2026-06-154LENZ Therapeutics, Inc. (LENZ)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 22,100 (derivative) @ $0EDGAR
2026-06-124Janux Therapeutics, Inc. (JANX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 5,500 @ $0 · Grant/award (A): 15,500 (derivative) @ $0EDGAR
2026-06-084Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 40,000 (derivative) @ $0EDGAR
2026-06-054Acumen Pharmaceuticals, Inc. (ABOS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 35,500 @ $0 · Grant/award (A): 53,250 (derivative) @ $0EDGAR
2026-05-204Acrivon Therapeutics, Inc. (ACRV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 9,366 @ $0EDGAR
2026-05-064Hemab Therapeutics Holdings, Inc. (COAG)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund IV, L.P., Kolchinsky Peter, Shah Rajeev M.
Conversion (C): 3,607,846 · Conversion (C): 1,009,052 · Conversion (C): 221,188 · Purchase (P): 2,541,250 @ $18 · Purchase (P): 133,750 @ $18 · Purchase (P): 87,143 @ $24.59 · +9 moreEDGAR
2026-04-294Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 2,106,000 (derivative) @ $9.50EDGAR
2026-04-234Acrivon Therapeutics, Inc. (ACRV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 3,888,888 @ $1.80EDGAR
2026-03-184Acumen Pharmaceuticals, Inc. (ABOS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 6,060,606 @ $3.30EDGAR
2026-01-074Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 7,111 @ $3.50EDGAR
2025-12-154Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., Kolchinsky Peter, Shah Rajeev M.
Disposition to issuer (D): 20,440,000 @ $0 · Purchase (P): 213,099 @ $2.18 · Purchase (P): 101,462 @ $2.86 · Grant/award (A): 20,440,000 (derivative)EDGAR
2025-09-304PepGen Inc. (PEPG)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 9,375,000 @ $3.20EDGAR
2025-06-274ARS Pharmaceuticals, Inc. (SPRY)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-174Acrivon Therapeutics, Inc. (ACRV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 20,275 (derivative) @ $0EDGAR
2025-06-134Janux Therapeutics, Inc. (JANX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 3,750 @ $0 · Grant/award (A): 11,667 (derivative) @ $0EDGAR
2025-06-114LENZ Therapeutics, Inc. (LENZ)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 13,500 (derivative) @ $0EDGAR
2025-06-064PepGen Inc. (PEPG)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 16,000 (derivative) @ $0EDGAR
2025-06-054Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-06-054Acumen Pharmaceuticals, Inc. (ABOS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 12,800 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR
2025-05-144Werewolf Therapeutics, Inc. (HOWL)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 320,913 @ $0.86 · Purchase (P): 52,974 @ $0.98 · Purchase (P): 162,539 @ $0.98EDGAR
2025-03-074Janux Therapeutics, Inc. (JANX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 304,287 @ $30.56 · Purchase (P): 37,455 @ $31.30 · Purchase (P): 372,093 @ $30.78 · Purchase (P): 110,206 @ $31.02EDGAR
2024-10-224Janux Therapeutics, Inc. (JANX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 1,200,000 @ $44.75EDGAR
2024-08-134AN2 Therapeutics, Inc. (ANTX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Sale (S): 3,410,335 @ $1.08 · Sale (S): 114,759 @ $1.08EDGAR
2024-07-014Eliem Therapeutics, Inc. (ELYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 973,000 · Grant/award (A): 2,479,872 · Grant/award (A): 1,807,000 · Purchase (P): 11,949,171 @ $3.84 · Purchase (P): 1,059,375 @ $3.84EDGAR
2024-06-284Janux Therapeutics, Inc. (JANX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 2,500 @ $0 · Grant/award (A): 8,350 (derivative) @ $0EDGAR
2024-06-284Eliem Therapeutics, Inc. (ELYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-244ARS Pharmaceuticals, Inc. (SPRY)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-244Acrivon Therapeutics, Inc. (ACRV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 20,275 (derivative) @ $0EDGAR
2024-06-214PepGen Inc. (PEPG)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 13,000 (derivative) @ $0EDGAR
2024-06-104Acumen Pharmaceuticals, Inc. (ABOS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-05-244Werewolf Therapeutics, Inc. (HOWL)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 17,500 (derivative) @ $0EDGAR
2024-04-154Acrivon Therapeutics, Inc. (ACRV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 3,530,000 @ $8.50EDGAR
2024-04-044Boundless Bio, Inc. (BOLD)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Conversion (C): 1,587,912 · Purchase (P): 296,875 @ $16 · Conversion (C): 280,219 · Purchase (P): 15,625 @ $16 · Conversion (C): 17,000,000 (derivative) @ $0 · Conversion (C): 3,000,000 (derivative) @ $0 · +2 moreEDGAR
2024-03-274ARS Pharmaceuticals, Inc. (SPRY)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 437,600 @ $9.06 · Purchase (P): 457,745 @ $9.55 · Purchase (P): 505,954 @ $9.79EDGAR
2024-03-254LENZ Therapeutics, Inc. (LENZ)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 2,386,301 · Grant/award (A): 694,755 · Grant/award (A): 164,729 · Purchase (P): 933,038 @ $15.03 · Purchase (P): 64,971 @ $15.03 · Grant/award (A): 54,582 (derivative) · +3 moreEDGAR
2024-03-064Janux Therapeutics, Inc. (JANX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 1,397,849 (derivative) @ $46.50EDGAR
2024-02-204Icosavax, Inc. (ICVX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Code (U): 5,543 · Code (U): 5,324,897 · Code (U): 638,668 · Disposition to issuer (D): 22,278 (derivative) · Disposition to issuer (D): 17,000 (derivative)EDGAR
2024-02-134PepGen Inc. (PEPG)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 2,557,593 @ $10.64EDGAR
2023-09-254ARS Pharmaceuticals, Inc. (SPRY)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 2,508,691 @ $2.97 · Purchase (P): 191,309 @ $3.83EDGAR
2023-08-314ARS Pharmaceuticals, Inc. (SPRY)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 3,750,000 @ $6.20EDGAR
2023-08-224AN2 Therapeutics, Inc. (ANTX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 1,777,778 @ $9EDGAR
2023-08-094DICE Therapeutics, Inc. (DICE)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Code (U): 7,070,205 · Code (U): 786,407 · Disposition to issuer (D): 21,250 (derivative)EDGAR
2023-07-254Acumen Pharmaceuticals, Inc. (ABOS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 5,161,290 @ $7.75EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1825376 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs